Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma
Clinical trial NCT00671268 · COMPLETED
Trial details
- NCT number
- NCT00671268
- Sponsor
- Allergopharma GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2012-03-01
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.